LifeMD Statistics
Share Statistics
LifeMD has 17.73M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding | 17.73M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 688 |
FTD / Avg. Volume | 11.45% |
Short Selling Information
The latest short interest is 2.21K, so 0% of the outstanding
shares have been sold short.
Short Interest | 2.21K |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.05 |
Valuation Ratios
The PE ratio is -10.8 and the forward
PE ratio is null.
LifeMD's PEG ratio is
0.44.
PE Ratio | -10.8 |
Forward PE | n/a |
PS Ratio | 0.96 |
Forward PS | 3.5 |
PB Ratio | 0 |
P/FCF Ratio | 34.12 |
PEG Ratio | 0.44 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for LifeMD.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.81,
with a Debt / Equity ratio of 0.
Current Ratio | 0.81 |
Quick Ratio | 0.76 |
Debt / Equity | 0 |
Debt / EBITDA | -3.77 |
Debt / FCF | 4.2 |
Interest Coverage | -7.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $698,861.31 |
Profits Per Employee | $-62,110.96 |
Employee Count | 304 |
Asset Turnover | 2.93 |
Inventory Turnover | -10.71 |
Taxes
Income Tax | 402K |
Effective Tax Rate | -2.19% |
Stock Price Statistics
The stock price has increased by 17.71% in the
last 52 weeks. The beta is 2.23, so LifeMD's
price volatility has been higher than the market average.
Beta | 2.23 |
52-Week Price Change | 17.71% |
50-Day Moving Average | 24 |
200-Day Moving Average | 22.71 |
Relative Strength Index (RSI) | 50.63 |
Average Volume (20 Days) | 6,011 |
Income Statement
In the last 12 months, LifeMD had revenue of 212.45M
and earned -18.88M
in profits. Earnings per share was -0.53.
Revenue | 212.45M |
Gross Profit | 242.4M |
Operating Income | -16.14M |
Net Income | -18.88M |
EBITDA | -6.65M |
EBIT | -16.14M |
Earnings Per Share (EPS) | -0.53 |
Full Income Statement Balance Sheet
The company has 35M in cash and 25.1M in
debt, giving a net cash position of 9.9M.
Cash & Cash Equivalents | 35M |
Total Debt | 25.1M |
Net Cash | 9.9M |
Retained Earnings | -236,253.2B |
Total Assets | 73.61M |
Working Capital | -10.93M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 17.51M
and capital expenditures -11.54M, giving a free cash flow of 5.98M.
Operating Cash Flow | 17.51M |
Capital Expenditures | -11.54M |
Free Cash Flow | 5.98M |
FCF Per Share | 0.15 |
Full Cash Flow Statement Margins
Gross margin is 114.1%, with operating and profit margins of -7.6% and -8.89%.
Gross Margin | 114.1% |
Operating Margin | -7.6% |
Pretax Margin | -8.63% |
Profit Margin | -8.89% |
EBITDA Margin | -3.13% |
EBIT Margin | -7.6% |
FCF Margin | 2.81% |